| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT07211607 | I.V. Selonabant in Healthy Adult Subjects | RECRUITING | PHASE1 | 2025-09-22 | 2026-08-25 | 2026-08-25 |
| NCT05282797 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test | COMPLETED | PHASE2 | 2021-12-15 | 2023-08-26 | 2023-08-26 |